InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Monday, 07/17/2017 2:35:34 PM

Monday, July 17, 2017 2:35:34 PM

Post# of 6378
I have had time to research our new BOD member. He appears to be well qualified. However, is he a "big hitter" whose appointment would help us on Wall Street or Cancer circles? I am uncertain on that point. He is not with a big pharma company. Avir's market cap is even lower than ours. The company where he is CFO may also be delisted.

(http://www.4-traders.com/AVIRAGEN-THERAPEUTICS-INC-27126328/news/AVIRAGEN-THERAPEUTICS-INC-Notice-of-Delisting-or-Failure-to-Satisfy-a-Continued-Listing-Rule-or-24153224/).

AVIR did successfully avoid delisting previously through a NASDAQ hearing in 2013 but before Mr. Colonesse was the CFO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News